Home/Filings/4/0000912282-23-000385
4//SEC Filing

Seizinger Bernd R. 4

Accession 0000912282-23-000385

CIK 0000882361other

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 5:03 PM ET

Size

12.4 KB

Accession

0000912282-23-000385

Insider Transaction Report

Form 4
Period: 2023-09-22
Transactions
  • Purchase

    Common Shares

    2023-09-22$3.14/sh+17,000$53,38017,000 total
Footnotes (1)
  • [F1]The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.13 to $3.14, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc.., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

Aptose Biosciences Inc.

CIK 0000882361

Entity typeother

Related Parties

1
  • filerCIK 0001789042

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 5:03 PM ET
Size
12.4 KB